Trial
NCT00857714
Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
GlaxoSmithKline
Condition
Ductal Carcinoma in Situ
Intervention
lapatinib
Why stopped
Terminated due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-08